Sanofi’s $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend February 22, 2011 CenterWatch Staff
New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising February 22, 2011 CenterWatch Staff